SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The community is rallying behind the multichain meme project crow with knife, highlighting its deflationary burn mechanism and organic growth as primary drivers of their bullish sentiment. Discussions are dominated by high-energy engagement and a strong conviction that the token serves as a unique asset within the current meme coin landscape.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging in popularity as the community rallies around its status as a long-standing parody of Bitcoin, with users debating whether its satirical roots give it staying power as a legitimate asset. Supporters are actively pointing to its unique lore, growing holder count, and high-profile endorsements as catalysts, while others remain skeptical, fueling a polarized discussion about its long-term potential in the meme coin space.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF (SMH) is trending as institutional investors debate whether the sector's aggressive AI-driven rally is facing a distribution phase or a continuation setup. The community is heavily focused on the disconnect between soaring AI infrastructure capex and mounting concerns over data center cancellations, power grid constraints, and valuation premiums.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently facing intense selling pressure and negative sentiment as investors express frustration over prolonged stagnant price action and its consistent underperformance compared to other assets. The community is actively debating the project's long-term utility versus its speculative nature, while many are focused on the impact of upcoming legislative developments and potential accumulation opportunities during this period of high volatility.

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DaVita Inc

DaVita is currently trending as investors weigh the potential long-term impact of GLP-1 weight-loss drugs on the demand for dialysis services, leading to significant market volatility. While some community members view the sharp price drop as a major overreaction based on distant speculation, others are actively debating the sustainability of the company's business model and debt load in light of emerging medical treatments.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is seeing intense market activity fueled by speculation over potential high-profile partnerships and its integration into the decentralized live music and event ecosystem. Community sentiment remains polarized, with many investors highlighting strong momentum and real-world utility while others caution against potential volatility and speculative 'pump and dump' patterns.

Maulcoin

Maulcoin is trending as its community aggressively rallies behind the project's organic growth and 'join the dark side' branding, with members actively pushing for social engagement and new listings to drive the next wave of price appreciation. Investors are heavily focused on holding through dips and hitting specific market cap milestones that trigger community-wide airdrops, highlighting a strong collective sentiment centered on long-term accumulation rather than short-term gains.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar is currently trending as a leading proxy for SpaceX, driven by investor optimism surrounding a potential high-valuation IPO and the company's significant equity stake acquired through recent spectrum deals. Market participants are actively debating the company's valuation metrics and the potential for a short squeeze, positioning the stock as a high-beta setup tied to the upcoming space sector catalysts.

IDEX

IDEX is trending as investors speculate on potential price breakouts, with the community actively debating whether the asset is primed for a rally driven by technical chart patterns and new protocol liquidity initiatives. Market participants are split between bullish sentiment regarding recent consolidation and skepticism fueled by the stock's history of volatility and rapid price swings.

TON (The Open Network) is a general-purpose&nbsp;blockchain that allows developers to build decentralized apps and tokens.

Toncoin

Toncoin is capturing market attention as its integration with Telegram reaches a massive user base, with traders highlighting recent sub-second network upgrades and high APY staking opportunities. Community discussion is currently centered on increased institutional adoption, including new ETP listings and strategic whale accumulation despite recent price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Research Reports for Bank of America, GE Aerospace & T-Mobile

BAC, GE, and TMUS anchor fresh research as analysts flag growth drivers, rising costs, and competitive pressures shaping outlooks across banking, aerospace, and telecom.

Is This the Right Time to Add Globus Medical Stock to Your Portfolio?

GMED rides on NuVasive synergies, strong cash flow and rapid innovation, but macro pressures and rising costs cloud its near-term outlook.

Alcon Stock Gains Following the Launch of Clareon TruPlus at ASCRS

ALC gains after launching Clareon TruPlus IOL, expanding its portfolio with enhanced depth of focus while maintaining high-quality distance vision.

Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada

This season, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that Systane has partnered with the Toronto Blue Jays as the official eye drop of the team...

Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of Clareon TruPlus, its new enhanced design monofocal and toric...

Alcon Publishes Agenda for 2026 Annual General Meeting

Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on April 30, 2026. Alcon is pleased to welcome shareholders to its fourth in-person AGM since becoming...

LENSAR Q4 Earnings Call Highlights

LENSAR (NASDAQ:LNSR) executives used the company's fourth-quarter and full-year 2025 earnings call to outline how the cataract-laser maker plans to reaccelerate growth as a standalone company...

LENSAR Stock Plunges Alcon Scraps Merger After Prolonged Regulatory Review

Alcon cancels $356 million LENSAR merger due to regulatory delays and FTC opposition, adding pressure on shares.read more...

<ul class="summary-bullets"><li>Lensar said in a statement that it is disappointed with the outcome and the Federal Trade Commission's intent to challenge the deal.</li><li>Alcon agreed to acquire LENSAR in March 2025 for a total potential consideration of up to $16.75 per share.</li><li>Lensar, despite the termination, will retain the $10.0 million deposit contemplated by the merger agreement, it said.</li></ul>&nbsp;Shares of LENSAR, Inc. (NSR) slumped 24% after hours on Monday after the company terminated its merger agreement with eye care company Alcon Research, LLC (ALC).The commercial-stage medical device company Lensar said on Monday that the company decided to terminate the deal after the two companies concluded that it is in the best interest of both. Lensar further added that the deal is unlikely to receive necessary regulatory approvals in the U.S. by April 23 or even by an extended deadline of July 23.Lensar said in a statement that it is disappointed with the outcome and the Federal Trade Commission's intent to challenge the deal.<h2 class="st-heading-2">The Deal That Fell Through</h2>Alcon agreed to acquire LENSAR in March 2025 for a total potential consideration of up to $16.75 per share. This included an upfront payment of $14 per share in cash and an additional non-tradeable contingent value right offering up to $2.75 per share in cash. Alcon then said that the transaction is anticipated to close in mid-to-late 2025.However, last month Lensar said that it now expects the transaction to close only by the first half of 2026 as the two companies continue to cater to the FTC’s demand for additional information pertaining to the acquisition.“...the delay and associated costs of this extended regulatory review, which began nearly a year ago, has rendered the transaction unattractive to pursue further in light of the Federal Trade Commission’s opposition,” said Alcon CEO David J. Endicott. Lensar, however, will retain the $10.0 million deposit contemplated by the merger agreement, it said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around LNSR stock stayed within the ‘bullish’ territory while sentiment around ALC remained ‘neutral’.<a href="https://stocktwits.com/symbol/LNSR">LNSR stock</a> has dropped 34% over the past 12 months while <a href="https://stocktwits.com/symbol/ALC">ALC shares</a> fell 13%.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/sarepta-shares-rise-as-company-begins-enrollment-in-gene-therapy-safety-enhancement-study/cZ3PezERIQd">Sarepta Shares Rise As Company Begins Enrollment In Gene Therapy Safety Enhancement Study</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In the wake of OWL's redemption restrictions, Senator Elizabeth Warren called for tighter oversight of private credit.

Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback

Lensar said that its deal with Alcon is unlikely to receive necessary regulatory approvals in the U.S. by April 23 or even by July 23. 

Equity

Lensar said that its deal with Alcon is unlikely to receive necessary regulatory approvals in the U.S. by April 23 or even by July 23. 


Alcon Ends Merger Agreement With LENSAR After FTC Opposition

(RTTNews) - Alcon Inc. (ALC) announced on Monday that it has agreed with LENSAR, Inc. (LNSR) to terminate their previously announced merger agreement...

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.

Current Price	$78.01
Prev Close	$77.40
Open	$79.11
Dividend Yield	0.42%
50-Day Moving Average	$79.09
Beta	0.76
Avg. Volume	1.49M
PE Ratio	39.26

52-Week High	$99.20
52-Week Low	$71.55
Market Capitalization	$38.02B
EPS (Annual)	$1.99
Price to Book	1.73
Revenue Per Employee	$400,932.85

ALC
Alcon Inc. - Registered Shares

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALC News

ALCAlcon Inc. - Registered Shares